Henry Schein (NASDAQ:HSIC) reported better-than-expected third-quarter results on Tuesday, as strong sales across all business segments drove growth and prompted the company to raise its full-year guidance.
The world’s leading provider of healthcare solutions for dental and medical practitioners posted adjusted earnings of $1.38 per share, topping analyst forecasts of $1.28, while revenue climbed 5.2% year-over-year to $3.34 billion, surpassing expectations of $3.28 billion.
“We are pleased with our financial results for the third quarter, with sales growth accelerating in each of our reportable segments including solid market share gains in our distribution businesses as we are once again focused on driving growth now that the cyber incident is fully behind us,” said Stanley M. Bergman, Chairman and CEO of Henry Schein.
The company’s global dental distribution merchandise sales rose 4.6% year-over-year, while medical distribution sales increased 4.7%. Meanwhile, global specialty products and technology sales posted gains of 5.9% and 9.7%, respectively.
Following its strong quarterly performance, Henry Schein raised its 2025 adjusted EPS guidance to $4.88–$4.96, up from the prior range of $4.80–$4.94, exceeding the analyst consensus of $4.82. The company also lifted its total sales growth forecast to 3–4% for 2025, compared with the earlier 2–4% projection.
Additionally, Henry Schein announced a series of value creation initiatives aimed at delivering over $200 million in operating income improvements over the next several years.
The company also revealed an agreement with KKR, allowing the investment firm to increase its ownership stake in Henry Schein to up to 19.9%, underscoring investor confidence in the company’s long-term strategy.